Skip to content

Ceramide Containing Multivesicular Emulsion Application . . .

Ceramide Containing Multivesicular Emulsion Application as a Skin Hydration Treatment for Feet of Subjects With Non-insulin Dependent Diabetes Mellitus.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00947726
Enrollment
10
Registered
2009-07-28
Start date
2009-07-01
Completion date
2010-07-31
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foot Dryness in Patients With NIDDM, Foot Transepidermal Water Loss in Patients in NIDDM

Brief summary

We believe that using a ceramide based foot cream two times a day for two weeks will prevent water loss and overall foot dryness in patients with non-insulin dependent diabetes.

Interventions

OTHERCeraVe

Using over the counter (OTC) cream on foot twice daily for two weeks.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lead SponsorNIH
The University of Texas Health Science Center, Houston
CollaboratorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \>18 years of age * non insulin-dependent diabetes * moderate to severe xerosis of both feet \[a score of at least 4 on a scale of 0 (normal) to 8 (deep fissuring)\] * capable of understanding and signing consent form

Exclusion criteria

* history of ichthyosis vulgaris * known hypersensitivity to the topical product used in the study * previous use of high potency steroids (class I and II) in past 2 week * presence of acute skin disease or infection, such as vasculitis or cellulitis * presence of foot ulcer * evidence of gangrene

Design outcomes

Primary

MeasureTime frame
Decrease transepidermal water loss and foot dryness in study subjects.Baseline and 5 weeks

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026